Medicine: SN 13,274

Malaria plagues nearly half the world's population. Since the war, researchers have been inching closer to a definitive cure for the disease. Last week it looked as if they just about had it—a new drug which, used with quinine, permanently cures 95% of all relapsing malaria cases. Still unnamed, it is identified as SN 13,274. The drug was developed at Columbia University, with U.S. Public Health Service aid, by a group of chemists headed by Dr. Robert C. Elderfield.

Relapsing malaria is difficult to cure because the tiny parasites that cause the disease lurk...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!